Regeneron drug tames eczema in study

July 10, 2014 12:09 AM

22 0

Regeneron drug tames eczema in study

PARIS/NEW YORK (Reuters) - An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc significantly reduced skin lesions and itching in adult patients with atopic dermatitis, a chronic form of eczema that is poorly controlled by standard drugs, the companies said on Wednesday.

The findings were seen in a Phase IIb, or mid-stage, trial of the injectable drug dupilumab, which is also being tested by the drugmakers against two other allergic conditions: asthma and nasal polyps.

Read more

To category page